Literature DB >> 22717677

A sympathetic view of human obesity.

Elisabeth A Lambert1, Nora E Straznicky, Gavin W Lambert.   

Abstract

Excess adiposity is associated with increased incidence of cardiovascular disease (CVD). Importantly, CVD mortality associated with obesity is more prevalent in young individuals. Elevated sympathetic nervous system (SNS) activity is present in obesity, even in individuals who are young and otherwise healthy. Baseline SNS overactivity, as well as blunted sympathetically mediated thermogenic response to a meal may play a critical role in the development and progression of CVD which is likely to develop as a result of multiple factors. Recent data indicate that SNS activity to the skeletal muscle is directly related to the degree of renal, endothelial and cardiac dysfunction in young individuals. Targeting the SNS may be an attractive and important avenue for the pharmacological treatment of obesity-related disturbances.

Entities:  

Mesh:

Year:  2012        PMID: 22717677     DOI: 10.1007/s10286-012-0169-3

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  33 in total

1.  Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.

Authors:  Kazuko Masuo; Hideki Kawaguchi; Hiroshi Mikami; Toshio Ogihara; Michael L Tuck
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

Review 2.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

3.  Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.

Authors:  Elisabeth A Lambert; Markus P Schlaich; Tye Dawood; Carolina Sari; Reena Chopra; David A Barton; David M Kaye; Mikael Elam; Murray D Esler; Gavin W Lambert
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

4.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

Review 5.  Moxonidine: a review of its use in essential hypertension.

Authors:  Caroline Fenton; Gillian M Keating; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation.

Authors:  Jennifer Logue; Heather M Murray; Paul Welsh; James Shepherd; Chris Packard; Peter Macfarlane; Stuart Cobbe; Ian Ford; Naveed Sattar
Journal:  Heart       Date:  2011-02-14       Impact factor: 5.994

7.  Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?

Authors:  P Lee; A-P Kengne; J R Greenfield; R O Day; J Chalmers; K K Y Ho
Journal:  Int J Obes (Lond)       Date:  2011-02-08       Impact factor: 5.095

8.  Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.

Authors:  Guido Grassi; Anna Facchini; Fosca Quarti Trevano; Raffaella Dell'Oro; Francesca Arenare; Francesco Tana; GianBattista Bolla; Anna Monzani; Maria Robuschi; Giuseppe Mancia
Journal:  Hypertension       Date:  2005-06-27       Impact factor: 10.190

9.  Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

Authors:  Nora E Straznicky; Gavin W Lambert; Kazuko Masuo; Tye Dawood; Nina Eikelis; Paul J Nestel; Mariee T McGrane; Justin A Mariani; Florentia Socratous; Reena Chopra; Murray D Esler; Markus P Schlaich; Elisabeth A Lambert
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

10.  Subcutaneous obesity is not associated with sympathetic neural activation.

Authors:  Guy E Alvarez; Tasha P Ballard; Stacy D Beske; Kevin P Davy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-26       Impact factor: 4.733

View more
  12 in total

Review 1.  Fifty years of microneurography: learning the language of the peripheral sympathetic nervous system in humans.

Authors:  J Kevin Shoemaker; Stephen A Klassen; Mark B Badrov; Paul J Fadel
Journal:  J Neurophysiol       Date:  2018-02-07       Impact factor: 2.714

Review 2.  Recruitment strategies in efferent sympathetic nerve activity.

Authors:  J Kevin Shoemaker
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

3.  Identification of genes whose expression is altered by obesity throughout the arterial tree.

Authors:  Jaume Padilla; Nathan T Jenkins; Pamela K Thorne; Jeffrey S Martin; R Scott Rector; J Wade Davis; M Harold Laughlin
Journal:  Physiol Genomics       Date:  2014-09-30       Impact factor: 3.107

4.  Adrenal medullary dysfunction as a feature of obesity.

Authors:  M Reimann; N Qin; M Gruber; S R Bornstein; C Kirschbaum; T Ziemssen; G Eisenhofer
Journal:  Int J Obes (Lond)       Date:  2017-02-06       Impact factor: 5.095

5.  Seasonal decrease in thermogenesis and increase in vasoconstriction explain seasonal response to N6 -cyclohexyladenosine-induced hibernation in the Arctic ground squirrel (Urocitellus parryii).

Authors:  Carla Frare; Mackenzie E Jenkins; Kelsey M McClure; Kelly L Drew
Journal:  J Neurochem       Date:  2019-08-29       Impact factor: 5.372

6.  Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation.

Authors:  Teresa Pellegrino; Valentina Piscopo; Antonio Boemio; Barbara Russo; Gianluca De Matteis; Sara Pellegrino; Sara Maria Delle Acque Giorgio; Manuela Amato; Mario Petretta; Alberto Cuocolo
Journal:  Quant Imaging Med Surg       Date:  2015-12

7.  Cardiovascular response to acute cold stress in non-obese and obese healthy adults.

Authors:  S Grewal; T S Sekhon; L Walia; R S Gambhir
Journal:  Ethiop J Health Sci       Date:  2015-01

8.  Acute cyclooxygenase inhibition does not alter muscle sympathetic nerve activity or forearm vasodilator responsiveness in lean and obese adults.

Authors:  Jill N Barnes; Nisha Charkoudian; Luke J Matzek; Christopher P Johnson; Michael J Joyner; Timothy B Curry
Journal:  Physiol Rep       Date:  2014-07-16

9.  Reduced lipolysis response to adipose afferent reflex involved in impaired activation of adrenoceptor-cAMP-PKA-hormone sensitive lipase pathway in obesity.

Authors:  Lei Ding; Feng Zhang; Ming-Xia Zhao; Xing-Sheng Ren; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

Review 10.  Metabolic syndrome and the hepatorenal reflex.

Authors:  Michael D Wider
Journal:  Surg Neurol Int       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.